C
AXIL Brands, Inc.
AXIL
$6.90
$0.101.47%
C
Hold
1/24/2025Upgraded
AXIL Brands, Inc. (AXIL) was upgraded to C from C- on 1/24/2025 due to an increase in the volatility index and total return index.
AXIL Brands, Inc. (AXIL) was upgraded to C from C- on 1/24/2025 due to an increase in the volatility index and total return index.
C
Hold
1/10/2025Upgraded
AXIL Brands, Inc. (AXIL) was upgraded to C- from D+ on 1/10/2025 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 578.25% from -$140.7 to $672.9, earnings per share increased from -$0.02 to $0.08, and total revenue increased 32.15% from $5.85M to $7.73M.
AXIL Brands, Inc. (AXIL) was upgraded to C- from D+ on 1/10/2025 due to a significant increase in the growth index, valuation index and total return index. EBIT increased 578.25% from -$140.7 to $672.9, earnings per share increased from -$0.02 to $0.08, and total revenue increased 32.15% from $5.85M to $7.73M.
D
Sell
10/31/2024Downgrade
AXIL Brands, Inc. (AXIL) was downgraded to D+ from C- on 10/31/2024 due to a decline in the total return index, volatility index and valuation index.
AXIL Brands, Inc. (AXIL) was downgraded to D+ from C- on 10/31/2024 due to a decline in the total return index, volatility index and valuation index.
C
Hold
10/11/2024Downgrade
AXIL Brands, Inc. (AXIL) was downgraded to C- from C on 10/11/2024 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 182.96% from $169.6 to -$140.7, earnings per share declined from $0.1509 to -$0.02, and total revenue declined 10% from $6.5M to $5.85M.
AXIL Brands, Inc. (AXIL) was downgraded to C- from C on 10/11/2024 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 182.96% from $169.6 to -$140.7, earnings per share declined from $0.1509 to -$0.02, and total revenue declined 10% from $6.5M to $5.85M.
C
Hold
8/2/2024Upgraded
AXIL Brands, Inc. (AXIL) was upgraded to C from C- on 8/2/2024 due to a noticeable increase in the valuation index and volatility index.
AXIL Brands, Inc. (AXIL) was upgraded to C from C- on 8/2/2024 due to a noticeable increase in the valuation index and volatility index.
C
Hold
5/31/2024Downgrade
AXIL Brands, Inc. (AXIL) was downgraded to C- from C on 5/31/2024 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 206.77% from $854.9 to -$912.8, EBIT declined 108.22% from $1.26M to -$103.9, and earnings per share declined from $0.0547 to $0.04.
AXIL Brands, Inc. (AXIL) was downgraded to C- from C on 5/31/2024 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 206.77% from $854.9 to -$912.8, EBIT declined 108.22% from $1.26M to -$103.9, and earnings per share declined from $0.0547 to $0.04.
C
Hold
8/22/2023Upgraded
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 8/22/2023 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.0004 to $0.0065, operating cash flow increased 383.2% from $123.8 to $598.2, and EBIT increased 169.25% from $216.6 to $583.2.
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 8/22/2023 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from $0.0004 to $0.0065, operating cash flow increased 383.2% from $123.8 to $598.2, and EBIT increased 169.25% from $216.6 to $583.2.
C
Hold
8/4/2023Downgrade
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 8/4/2023 due to a large decline in the total return index, efficiency index and volatility index.
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 8/4/2023 due to a large decline in the total return index, efficiency index and volatility index.
C
Hold
7/20/2023Upgraded
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 7/20/2023 due to a noticeable increase in the total return index, volatility index and valuation index.
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 7/20/2023 due to a noticeable increase in the total return index, volatility index and valuation index.
C
Hold
7/5/2023Downgrade
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 7/5/2023 due to a decline in the total return index and valuation index.
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 7/5/2023 due to a decline in the total return index and valuation index.
C
Hold
5/16/2023Upgraded
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 5/16/2023 due to an increase in the total return index and volatility index.
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 5/16/2023 due to an increase in the total return index and volatility index.
C
Hold
4/14/2023Downgrade
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 4/14/2023 due to a major decline in the growth index. Operating cash flow declined 91.08% from $1.39M to $123.8, earnings per share declined from $0.002 to $0.0004, and EBIT declined 78.01% from $985 to $216.6.
Reviv3 Procare Company (RVIV) was downgraded to C- from C on 4/14/2023 due to a major decline in the growth index. Operating cash flow declined 91.08% from $1.39M to $123.8, earnings per share declined from $0.002 to $0.0004, and EBIT declined 78.01% from $985 to $216.6.
C
Hold
1/11/2023Upgraded
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 1/11/2023 due to a major increase in the growth index, efficiency index and total return index. EBIT increased 393.98% from $199.4 to $985, net income increased 314.19% from $175.5 to $726.9, and earnings per share increased from $0.0006 to $0.002.
Reviv3 Procare Company (RVIV) was upgraded to C from C- on 1/11/2023 due to a major increase in the growth index, efficiency index and total return index. EBIT increased 393.98% from $199.4 to $985, net income increased 314.19% from $175.5 to $726.9, and earnings per share increased from $0.0006 to $0.002.
C
Hold
12/27/2022Upgraded
Reviv3 Procare Company (RVIV) was upgraded to C- from D+ on 12/27/2022 due to a large increase in the total return index and volatility index.
Reviv3 Procare Company (RVIV) was upgraded to C- from D+ on 12/27/2022 due to a large increase in the total return index and volatility index.
D
Sell
10/13/2022Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D+ from D on 10/13/2022 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 2,394.32% from -$35.2 to $807.6, total capital increased 1,020.78% from $419.1 to $4.7M, and total revenue increased 704.37% from $526.8 to $4.24M.
Reviv3 Procare Company (RVIV) was upgraded to D+ from D on 10/13/2022 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 2,394.32% from -$35.2 to $807.6, total capital increased 1,020.78% from $419.1 to $4.7M, and total revenue increased 704.37% from $526.8 to $4.24M.
D
Sell
5/16/2022Upgraded
AXIL Brands, Inc. (AXIL) was upgraded to D from E+ on 05/16/2022.
AXIL Brands, Inc. (AXIL) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
AXIL Brands, Inc. (AXIL) was downgraded to E+ from D on 05/13/2022.
AXIL Brands, Inc. (AXIL) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index. Debt to equity increased from 0.8 to 1.14, and the quick ratio declined from 0.81 to 0.68.
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index. Debt to equity increased from 0.8 to 1.14, and the quick ratio declined from 0.81 to 0.68.
D
Sell
3/15/2022Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 3/15/2022 due to an increase in the volatility index.
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 3/15/2022 due to an increase in the volatility index.
D
Sell
1/25/2022Downgrade
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 1/25/2022 due to a large decline in the solvency index, total return index and growth index. Operating cash flow declined 538.55% from $8.3 to -$36.4, total revenue declined 41.17% from $839.3 to $493.8, and the quick ratio declined from 1.09 to 0.81.
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 1/25/2022 due to a large decline in the solvency index, total return index and growth index. Operating cash flow declined 538.55% from $8.3 to -$36.4, total revenue declined 41.17% from $839.3 to $493.8, and the quick ratio declined from 1.09 to 0.81.
D
Sell
11/9/2021Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
Reviv3 Procare Company (RVIV) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the growth index and volatility index.
Reviv3 Procare Company (RVIV) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the growth index and volatility index.
D
Sell
1/13/2021Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 1/13/2021 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 685.16% from $18.2 to $142.9, EBIT increased 180.29% from -$68 to $54.6, and earnings per share increased from -$0.0017 to $0.0013.
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 1/13/2021 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 685.16% from $18.2 to $142.9, EBIT increased 180.29% from -$68 to $54.6, and earnings per share increased from -$0.0017 to $0.0013.
D
Sell
10/8/2020Downgrade
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 10/8/2020 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 7,655.56% from $900 to -$68, operating cash flow declined 82.21% from $102.3 to $18.2, and the quick ratio declined from 1.74 to 0.94.
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 10/8/2020 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 7,655.56% from $900 to -$68, operating cash flow declined 82.21% from $102.3 to $18.2, and the quick ratio declined from 1.74 to 0.94.
D
Sell
8/21/2020Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 8/21/2020 due to a substantial increase in the growth index, volatility index and valuation index. Total revenue increased 153.7% from $157.9 to $400.6, operating cash flow increased 152.76% from -$193.9 to $102.3, and EBIT increased 100.97% from -$41.1 to $400.
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 8/21/2020 due to a substantial increase in the growth index, volatility index and valuation index. Total revenue increased 153.7% from $157.9 to $400.6, operating cash flow increased 152.76% from -$193.9 to $102.3, and EBIT increased 100.97% from -$41.1 to $400.
D
Sell
5/20/2020Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D- from E+ on 5/20/2020 due to an increase in the growth index, volatility index and valuation index.
Reviv3 Procare Company (RVIV) was upgraded to D- from E+ on 5/20/2020 due to an increase in the growth index, volatility index and valuation index.
E
Sell
4/8/2020Downgrade
Reviv3 Procare Company (RVIV) was downgraded to E+ from D- on 4/8/2020 due to a substantial decline in the growth index, efficiency index and volatility index. Operating cash flow declined 2,523.75% from $8 to -$193.9, total revenue declined 51.95% from $328.6 to $157.9, and earnings per share declined from -$0.0007 to -$0.001.
Reviv3 Procare Company (RVIV) was downgraded to E+ from D- on 4/8/2020 due to a substantial decline in the growth index, efficiency index and volatility index. Operating cash flow declined 2,523.75% from $8 to -$193.9, total revenue declined 51.95% from $328.6 to $157.9, and earnings per share declined from -$0.0007 to -$0.001.
D
Sell
4/1/2020Downgrade
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 4/1/2020 due to a decline in the volatility index, valuation index and total return index.
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 4/1/2020 due to a decline in the volatility index, valuation index and total return index.
D
Sell
3/17/2020Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 3/17/2020 due to an increase in the volatility index and valuation index.
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 3/17/2020 due to an increase in the volatility index and valuation index.
D
Sell
2/27/2020Downgrade
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 2/27/2020 due to a decline in the volatility index and total return index.
Reviv3 Procare Company (RVIV) was downgraded to D- from D on 2/27/2020 due to a decline in the volatility index and total return index.
D
Sell
2/12/2020Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 2/12/2020 due to an increase in the efficiency index and valuation index. Net income increased 69.78% from -$100.6 to -$30.4.
Reviv3 Procare Company (RVIV) was upgraded to D from D- on 2/12/2020 due to an increase in the efficiency index and valuation index. Net income increased 69.78% from -$100.6 to -$30.4.
D
Sell
9/3/2019Upgraded
Reviv3 Procare Company (RVIV) was upgraded to D- from E on 9/3/2019 due to an increase in the growth index, solvency index and efficiency index. The quick ratio increased from 1.86 to 8.16, EBIT increased 242.86% from -$3.5 to $5, and net income increased 236.11% from -$3.6 to $4.9.
Reviv3 Procare Company (RVIV) was upgraded to D- from E on 9/3/2019 due to an increase in the growth index, solvency index and efficiency index. The quick ratio increased from 1.86 to 8.16, EBIT increased 242.86% from -$3.5 to $5, and net income increased 236.11% from -$3.6 to $4.9.
E
Sell
6/3/2019Upgraded
Reviv3 Procare Company (RVIV) was upgraded to E from E- on 6/3/2019 due to a large increase in the solvency index, growth index and efficiency index. Operating cash flow increased 144.55% from -$60.6 to $27, EBIT increased 93.98% from -$58.1 to -$3.5, and net income increased 93.79% from -$58 to -$3.6.
Reviv3 Procare Company (RVIV) was upgraded to E from E- on 6/3/2019 due to a large increase in the solvency index, growth index and efficiency index. Operating cash flow increased 144.55% from -$60.6 to $27, EBIT increased 93.98% from -$58.1 to -$3.5, and net income increased 93.79% from -$58 to -$3.6.
E
Sell
3/4/2019None
AXIL Brands, Inc. (AXIL) was downgraded to E- from U on 03/04/2019.
AXIL Brands, Inc. (AXIL) was downgraded to E- from U on 03/04/2019.
AMEX
03/07/2025 4:00PM Eastern
Quotes delayed
